Benchmark Reaffirms “Buy” Rating for NeoGenomics (NASDAQ:NEO)
NeoGenomics (NASDAQ:NEO – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Benchmark in a research note issued on Tuesday, Benzinga reports. They currently have a $18.00 target price on the medical research company’s stock. Benchmark’s price target points to a potential upside of 20.32% from the company’s previous close. Several other […]
More Stories
Netflix’s Upcoming Drama, All the Truth in My Lies: Release Date, Cast, and More
Excited to know about the upcoming Spanish drama on Netflix, All the Truth in My Lies. If you love watching...
Obsession (2026): Release Date, Cast Members, Trailer, Plot, and More
Be Alert: Spoilers Ahead! Are you also a lover of horror shows and looking for upcoming horror movies and series...
Desire 2026: Release Date, Cast Members, Trailer, Audio, and More
Netflix is expanding its international movie lineup with intense action, thriller, and drama that explore the complexities of human emotions....
AI Assistants Overwhelmingly Cite Third-Party Lists, Not Company Homepages, Study Finds
Artificial intelligence assistants overwhelmingly cite third-party “best-of” and comparison pages rather than companies’ own websites, according to a new study...
How Businesses are Incorporating AI Video Into Sales Processes
Over the last few years, businesses have had to rethink their traditional sales processes. Consumers are more empowered to complete...
Margaret and Jack got separated after 3 Years of Marriage!
For everyone who is searching for the recent trendy news about the separation of Margaret Qualley and Jack Antonoff, here...